Qube Research & Technologies (QRT)
MDLN

Qube Research & Technologies (QRT)’s Medline Inc MDLN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47M Buy
+1,057,071
New +$46.7M 0.05% 452

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MDLN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Medline Inc (MDLN) in Q1 2026: 1,057,071 shares worth $47M. The stake represents 0.05% of the portfolio and ranks #452 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 1,057,071 shares of Medline Inc worth $47M as of Q1 2026.
  • Medline Inc was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Medline Inc made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #452 holding.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.